Effectiveness of CoronaVac and BNT162b2 COVID-19 mass vaccination in Colombia: a population-based cohort study

Background In February 2021, Colombia began mass vaccination against COVID-19 using mainly BNT162b2 and CoronaVac vaccines. We aimed to estimate vaccine effectiveness (VE) to prevent COVID-19 symptomatic cases, hospitalization, critical care admission, and deaths in a cohort of 796,072 insured subje...

Full description

Autores:

Paternina-Caicedo, Angel
Jit, Mark
Alvis-Guzmán, Nelson
Fernández, Juan Carlos
Hernández, José
Paz-Wilches, Justo Jesús
Rojas-suarez, Jose
Duenas-Castell, Carmelo
ALVIS-ZAKZUK, NELSON J.
Smith, Adrian D.
DE LA HOZ RESTREPO, FERNANDO

Tipo de recurso:

Article of journal

Fecha de publicación:

2022

Institución:

Corporación Universidad de la Costa

Repositorio:

REDICUC - Repositorio CUC

Idioma:

eng

OAI Identifier:

oai:repositorio.cuc.edu.co:11323/9373

Acceso en línea:

https://hdl.handle.net/11323/9373
https://doi.org/10.1016/j.lana.2022.100296
https://repositorio.cuc.edu.co/

Palabra clave:

Vaccine effectiveness
Covid-19
Mortality
Vaccines

Rights

openAccess

License

Atribución 4.0 Internacional (CC BY 4.0)